Enanta Pharmaceuticals, Inc. Insider Transactions
Enanta Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Rottinghaus Scott T.
Chief Medical Officer |
Sell | 5,375 @ $17.08 | $91,805 | 21,717 | 07/15/2024 | 07/15/2024 | |
|
Rottinghaus Scott T.
Chief Medical Officer |
Sell | 2,271 @ $15.04 | $34,156 | 21,717 | 07/12/2024 | 07/15/2024 | |
|
Rottinghaus Scott T.
Chief Medical Officer |
Sell | 4,299 @ $15.07 | $64,786 | 23,988 | 07/11/2024 | 07/15/2024 | |
|
Kieffer Tara Lynn
Chief Product Strategy Officer |
Sell | 7,266 @ $12.33 | $89,590 | 32,341 | 06/17/2024 | 06/17/2024 | |
|
Vance Terry
Director |
Sell | 15,295 @ $9.12 | $139,490 | 5,800 | 12/13/2023 | 12/15/2023 | |
|
Luu Brendan
Sr. VP, Business Dev. |
Sell | 2,125 @ $9.63 | $20,464 | 36,736 | 12/05/2023 | 12/06/2023 | |
|
Kieffer Tara Lynn
Sr. VP, New Prod. Strat. & Dev |
Sell | 2,125 @ $9.63 | $20,464 | 37,260 | 12/05/2023 | 12/06/2023 | |
|
Gardiner Nathaniel S.
Sr. VP & General Counsel |
Sell | 2,412 @ $9.63 | $23,228 | 68,154 | 12/05/2023 | 12/06/2023 | |
|
Rottinghaus Scott T.
Sr. VP & CMO |
Sell | 534 @ $9.63 | $5,142 | 26,466 | 12/05/2023 | 12/06/2023 | |
|
Or Yat Sun
Sr. VP, R&D & CSO |
Sell | 2,412 @ $9.63 | $23,228 | 370,695 | 12/05/2023 | 12/06/2023 | |
|
MELLETT PAUL J
Sr. VP, Finance & Admin. & CFO |
Sell | 2,412 @ $9.63 | $23,228 | 93,549 | 12/05/2023 | 12/06/2023 | |
|
Luly Jay R.
CEO |
Sell | 7,230 @ $9.63 | $69,625 | 806,793 | 12/05/2023 | 12/06/2023 | |
|
MELLETT PAUL J
Treasurer and CFO |
Sell | 100 @ $43.96 | $4,396 | 107,896 | 03/15/2023 | 03/17/2023 | |
|
MELLETT PAUL J
Treasurer and CFO |
Sell | 10,340 @ $44.43 | $459,406 | 97,556 | 03/15/2023 | 03/17/2023 | |
|
Or Yat Sun
Sr. VP & CSO |
Sell | 269 @ $43.92 | $11,814 | 388,358 | 03/15/2023 | 03/17/2023 | |
|
Or Yat Sun
Sr. VP & CSO |
Sell | 13,656 @ $44.46 | $607,146 | 374,702 | 03/15/2023 | 03/17/2023 | |
|
Luly Jay R.
CEO |
Sell | 10,697 @ $44.81 | $479,333 | 837,025 | 03/13/2023 | 03/14/2023 | |
|
Luly Jay R.
CEO |
Sell | 15,649 @ $45.31 | $709,056 | 821,376 | 03/13/2023 | 03/14/2023 | |
|
Luly Jay R.
CEO |
Sell | 1,566 @ $46.13 | $72,240 | 819,810 | 03/13/2023 | 03/14/2023 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enanta Pharmaceuticals, Inc. FAQ's
The list of insiders at Enanta Pharmaceuticals, Inc. includes Kieffer Tara Lynn, Rottinghaus Scott T..
Insiders have sold a total of 19,211 Enanta Pharmaceuticals, Inc. shares in the last 12 months for a total of 280,337 sold.
The following insiders have sold Enanta Pharmaceuticals, Inc. shares in the last 12 months: Kieffer Tara Lynn ($89,590), Rottinghaus Scott T. ($190,747),